drugset / Trial / NCT00522743

Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.

NCT00522743 ↗

Completed 17 enrolled Rabin Medical Center Pfizer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A 2-arms randomized open prospective intervention study to determine the Growth and metabolic response to growth hormone and gonadotropin-releasing hormone agonist treatment versus growth hormone alone in boys born SGA. All subjects will be treated with NorditropinSimplex at a dosage of 100mcg/kg/d. At onset of puberty, subjects will be randomized into either combined treatment with GH and GnRHa or GH alone.

Timeline

Start
2005-05
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject NorditropinSimplex Protein / enzyme biologic 100 ug/kg —